Acute Myeloid Leukemia Acquiring Promyelocytic Leukemia-Retinoic Acid Receptor Alpha at Relapse

Varsha Gupta1, Mohammed Shariff1, Ravneet Bajwa1

  • 1Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, NJ, USA.

Insights

This study reports a rare case of acute promyelocytic leukemia (APL) relapsing after AML chemotherapy. The patient achieved remission with ATRA and arsenic trioxide therapy after secondary PML-RARA acquisition.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) with a high cure rate.
  • Standard chemotherapy for AML was administered to a patient with a rare presentation of the disease.
  • The genetic hallmark of APL, the t(15;17) translocation, was absent at initial diagnosis.

Observation:

  • A patient initially diagnosed with AML relapsed after one year of chemotherapy.
  • The relapsed disease exhibited the characteristic t(15;17) translocation, forming the PML-RARA fusion gene.
  • This genetic abnormality was not detected at the time of the initial AML diagnosis.

Findings:

  • The patient achieved complete remission after treatment with all-trans retinoic acid (ATRA) and arsenic trioxide.
  • The secondary acquisition of the PML-RARA fusion gene at relapse is a key finding.
  • This suggests a potential mechanism for disease evolution in certain AML cases.

Implications:

  • This case highlights the importance of reassessing genetic profiles at relapse in AML.
  • Understanding the secondary acquisition of PML-RARA may lead to novel therapeutic strategies for APL.
  • Further research into the mechanisms of secondary genetic alterations in leukemia is warranted.

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.7K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.6K
Amino acids03:42

Amino acids

Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
104.7K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.3K
The Citric Acid Cycle02:36

The Citric Acid Cycle

The citric acid cycle, also known as the Krebs cycle or TCA cycle, consists of several energy-generating reactions that yield one ATP molecule, three NADH molecules, one FADH2 molecule, and two CO2 molecules.
161.6K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
960